Results 121 to 130 of about 22,299 (230)

Nerve growth factor gene polymorphisms may be associated with heroin dependence in women but do not mediate specific personality traits. [PDF]

open access: yesEur Arch Psychiatry Clin Neurosci
Kuo SC   +7 more
europepmc   +1 more source

GRK5 Is Associated with the Regulation of Methadone Dosage in Heroin Dependence. [PDF]

open access: yesInt J Neuropsychopharmacol, 2018
Wang SC   +9 more
europepmc   +1 more source

MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential

open access: yesMedComm – Future Medicine, Volume 5, Issue 1, March 2026.
The use of METH leads to the release of dopamine from the affected brain regions, including the nucleus accumbens (NAc), ventral tegmental area (VTA), prefrontal cortex (PFC), hippocampus (Hip), and striatum. This triggers signals that alter miRNA expression, which in turn leads to differential expression of target genes.
Yacoubou Abdoul Razak Mahaman   +7 more
wiley   +1 more source

Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence. [PDF]

open access: yesSubst Abuse Treat Prev Policy
Charkhat Gorgich EA   +4 more
europepmc   +1 more source

Free Flap Reconstruction of Xylazine‐Associated Wounds: A Retrospective Review

open access: yesMicrosurgery, Volume 46, Issue 3, March 2026.
ABSTRACT Background Xylazine is a veterinary sedative that is added to illicit fentanyl to enhance its effects. Xylazine‐associated wounds differ from those found in patients who inject other drugs. They are larger and frequently involve deeper structures, such as bone.
Alan T. Makhoul   +9 more
wiley   +1 more source

Xylazine test strip utilization among pregnant and postpartum women with opioid use disorder: A pilot study

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Introduction The emergence of xylazine, a veterinary alpha‐2 and kappa opioid receptor agonist, as an adulterant in illicitly manufactured fentanyl has created new challenges and risks for pregnant people who use unregulated opioids. Xylazine test strips (XTSs) have been proposed as a harm reduction strategy, but their use has not been studied
Ilana Hull   +7 more
wiley   +1 more source

Illicit Drug‐Derived Volatile Organic Compounds as Markers for Application in Noncontact Detection Technology

open access: yesThe Chemical Record, Volume 26, Issue 3, March 2026.
This review highlights the characteristic odor markers of illicit drugs, emphasizing volatile markers from both natural and synthetic sources, and explores the shift from canine‐based detection to emerging noncontact sensing technologies. Illicit drug use remains a global concern, requiring effective detection methods to counter evolving concealment ...
Minwoo Kim   +4 more
wiley   +1 more source

Drug Use After Emergency Department‐Initiated Injectable Buprenorphine: A Secondary Analysis of the ED‐INNOVATION Ancillary Safety and Feasibility Trial

open access: yesAcademic Emergency Medicine, Volume 33, Issue 3, March 2026.
ABSTRACT Study Objective To characterize opioid and nonopioid drug use in the week following emergency department (ED)‐initiated extended‐release buprenorphine (XR‐BUP) treatment using both self‐reported data and urine drug screens (UDS). Methods This study uses data collected during a nonrandomized clinical trial of patients with untreated opioid use ...
Ethan Cowan   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy